Cargando…
Association of treatment-emergent symptoms identified by patient-reported outcomes with adjuvant endocrine therapy discontinuation
Many patients discontinue endocrine therapy for breast cancer due to intolerance. Identification of patients at risk for discontinuation is challenging. The minimal important difference (MID) is the smallest change in a score on a patient-reported outcome (PRO) that is clinically significant. We eva...
Autores principales: | Smith, Karen Lisa, Verma, Neha, Blackford, Amanda L., Lehman, Jennifer, Westbrook, Kelly, Lim, David, Fetting, John, Wolff, Antonio C., Jelovac, Daniela, Miller, Robert S., Connolly, Roisin, Armstrong, Deborah K., Nunes, Raquel, Visvanathan, Kala, Riley, Carol, Papathakis, Katie, Zafman, Nelli, Sheng, Jennifer Y., Snyder, Claire, Stearns, Vered |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023490/ https://www.ncbi.nlm.nih.gov/pubmed/35449210 http://dx.doi.org/10.1038/s41523-022-00414-0 |
Ejemplares similares
-
A randomized intervention involving family to improve communication in breast cancer care
por: Wolff, Jennifer L., et al.
Publicado: (2021) -
Optimizing Vitamin D Concentrations for Breast Cancer Risk Reduction
por: Stearns, Vered, et al.
Publicado: (2013) -
Endocrine Therapy Nonadherence and Discontinuation in Black and White Women
por: Wheeler, Stephanie B, et al.
Publicado: (2018) -
Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast Cancer
por: Hertz, Daniel L., et al.
Publicado: (2021) -
Innovating and expanding weight loss strategies for breast cancer survivors
por: Sheng, Jennifer Y., et al.
Publicado: (2021)